ResearcherTorrance Memorial Medical CenterNo recent work listed
Bryan William Chang
Matched on OpenAlex author ID A5110204387. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper
Papers 8
- Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer. Co-author DOI 10.21037/jgo.2018.04.03↗
- A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease. Co-author DOI 10.7759/cureus.1007↗
- Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. Co-author DOI 10.1038/bjc.2016.45↗
- Capecitabine as a Radiosensitizer in Adjuvant Chemoradiotherapy for Pancreatic Cancer: A Retrospective Study. Co-author PMID 26637914↗
- Locally advanced unresectable pancreatic cancer. Last author DOI 10.6092/1590-8577/2684↗
- A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer. First author DOI 10.3978/j.issn.2078-6891.2013.011↗
- New possibilities and potential benefits for local control in locally recurrent pancreatic cancer. First author DOI 10.3978/j.issn.2078-6891.2013.049↗
- Treatment of locally advanced pancreatic cancer: the role of radiation therapy. Last author DOI 10.1016/j.ijrobp.2011.08.008↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kimberly L. Johung · 4 shared papers, 2012–2018 · strength 0.30
- Paper A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometas… DOI 10.7759/cureus.1007↗
- Paper Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer. DOI 10.21037/jgo.2018.04.03↗
- Paper Locally advanced unresectable pancreatic cancer. DOI 10.6092/1590-8577/2684↗
- Shane A. J. Lloyd · 3 shared papers, 2013–2018 · strength 0.24
- Paper Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer. DOI 10.21037/jgo.2018.04.03↗
- Paper A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer. DOI 10.3978/j.issn.2078-6891.2013.011↗
- Paper New possibilities and potential benefits for local control in locally recurrent pancreatic cancer. DOI 10.3978/j.issn.2078-6891.2013.049↗
- Muhammad Wasif Saif · 3 shared papers, 2012–2015 · strength 0.18
- Paper Locally advanced unresectable pancreatic cancer. DOI 10.6092/1590-8577/2684↗
- Paper Capecitabine as a Radiosensitizer in Adjuvant Chemoradiotherapy for Pancreatic Cancer: A Retrospective Study. PMID 26637914↗
- Paper Treatment of locally advanced pancreatic cancer: the role of radiation therapy. DOI 10.1016/j.ijrobp.2011.08.008↗
- Howard S. Höchster · 2 shared papers, 2016–2017 · strength 0.14
- Stacey Stein · 2 shared papers, 2016–2018 · strength 0.14
- Jill Lacy · 2 shared papers, 2016–2018 · strength 0.14
- John M Stahl · 1 shared paper, 2017 · strength 0.09
- Charles E. Rutter · 1 shared paper, 2018 · strength 0.09
- Brandon R. Mancini · 1 shared paper, 2018 · strength 0.09
- Kathryn E. Huber · 1 shared paper, 2015 · strength 0.06
- Suzanne M. Russo · 1 shared paper, 2015 · strength 0.06
- Matthew J. Abrams · 1 shared paper, 2015 · strength 0.06
- Charles H. Cha · 1 shared paper, 2016 · strength 0.05
- Ronald R. Salem · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.